Cataract

Lensar announces FDA clearance for ALLY Adaptive Cataract Treatment System

Lensar announced it has received U.S. Food and Drug Administration 510(k) clearance for its next-generation ALLY Adaptive Cataract Treatment System, according to a company press release. This is the first FDA-cleared system enabling surgeons to complete femtosecond-laser-assisted cataract (FLACS) procedure surgery in a single, sterile environment. A targeted initial launch...